To investigate the molecular mechanisms by which TACC3 promotes malignant phenotypes in bladder cancer, we performed RNA-seq analysis of 5637 cells with stable TACC3 knockdown compared to control cells (Fig. 2A). The gene discussed is TACC3; the disease is urinary bladder cancer.